https://www.thebody.com/category/hiv-drugs-development
HIV Treatment and Medical Care

HIV Drugs In Development

The Latest

prescription heap
Features

HIV Drugs in Clinical Trials to Treat COVID-19—What You Need to Know

While it may be months or years before effective treatments emerge, the HIV research of the past few decades has given us a head start.

By Michael Broder
Screenshot from Carl Dieffenbach and Anne Rancourt Final IAS 2019 Video
News Analysis

Updates on HIV Treatment Advances and Other Notes From IAS 2019

NIAID's Carl Dieffenbach, Ph.D., joins Anne Rancourt to discuss some key takeaways from the 10th International AIDS Society Conference on HIV Science.

By HIV.gov
An Overview of Valproic Acid Img

An Overview of Valproic Acid

Other Names: Depakene, Depakote, Depakote ER, Epival, VPA, divalproex sodium, valproate Drug Class: Latency-Reversing Agents Molecular Formula: C8 H16 O2 Registry Number: 99-66-1 (CAS) Chemical Name: 2-propylpentanoic acid Chemical Class: O...

By AIDSinfo
An Overview of Trogarzo (Ibalizumab-Uiyk) Img

An Overview of Trogarzo (Ibalizumab-Uiyk)

Brand Name: Trogarzo Other Name(s): Hu5A8, IBA, Ibalizumab-uiyk, TMB-355, TNX-355 Drug Class: Post-attachment Inhibitor Company: TaiMed Biologics USA Corp.

WARNING:Ibalizumab can cause serious, life-threatening side effects, including changes in you...

By AIDSinfo
An Overview of Elvucitabine Img

An Overview of Elvucitabine

Other Names: ACH-126443, ELV, L-F-D4C, beta-L-Fd4C, l(-)Fd4C Drug Class: Nucleoside Reverse Transcriptase Inhibitors Molecular Formula: C9 H10 F N3 O3 Registry Number: 181785-84-2 (CAS) Chemical Name: 4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,...

By AIDSinfo
What Is a Therapeutic HIV Vaccine? Img

What Is a Therapeutic HIV Vaccine?

Unlike a preventive HIV vaccine, a therapeutic HIV vaccine is designed to improve the body's immune response to HIV in people who are already infected with the virus. In the future, these vaccines could eliminate HIV from the body, or improve the bod...

By AIDSinfo
PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input Img
News

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input

Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.

By Jennifer Johnson Avril
Joseph Eron, Jr., M.D., presents 96-week study data from LATTE-2, at IAS 2017 (Credit: Warren Tong)
News

Long-Acting Injectable HIV Treatment Moves Closer to Reality

Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.

By Warren Tong
Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists Img
News

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists

The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...

By Sony Salzman
Real or Not? HIV Cure in Animals Using CRISPR Gene Editing Img
News

Real or Not? HIV Cure in Animals Using CRISPR Gene Editing

You may have heard about the "HIV cure with gene editing in animals" story. Here's some help making sense of the story, including what's true or not, and what to get excited about.

By Warren Tong